Abilify en es it fr

Abilify Brand names, Abilify Analogs

Abilify Brand Names Mixture

  • No information avaliable

Abilify Chemical_Formula


Abilify RX_link


Abilify fda sheet

Abilify FDA

Abilify msds (material safety sheet)

Abilify Synthesis Reference

No information avaliable

Abilify Molecular Weight

448.385 g/mol

Abilify Melting Point

No information avaliable

Abilify H2O Solubility

No information avaliable

Abilify State


Abilify LogP


Abilify Dosage Forms

No information avaliable

Abilify Indication

For the treatment of schizophrenia

Abilify Pharmacology

Aripiprazole is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. Aripiprazole is a selective monoaminergic antagonist with high affinity for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), 1 and 2 adrenergic, and H1 histaminergic receptors. Aripiprazole acts as an antagonist at other receptors, but with lower potency. Antagonism at receptors other than dopamine and 5HT2 with similar receptor affinities may explain some of the other therapeutic and side effects of Aripiprazole. Aripiprazole's antagonism of histamine H1 receptors may explain the somnolence observed with this drug. Aripiprazole's antagonism of adrenergic a1 receptors may explain the orthostatic hypotension observed with this drug.

Abilify Absorption

No information avaliable

Abilify side effects and Toxicity

No information avaliable

Abilify Patient Information

Abilify Organisms Affected

Humans and other mammals